The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter.
Open accessAbstract
A second isoform of the human vesicular monoamine transporter (hVMAT) has been cloned from a pheochromocytoma cDNA library. The contribution of the two transporter isoforms to monoamine storage in human neuroendocrine tissues was examined with isoform-specific polyclonal antibodies against hVMAT1 and hVMAT2. Central, peripheral, and enteric neurons express only VMAT2. VMAT1 is expressed exclusively in neuroendocrine, including chromaffin and enterochromaffin, cells. VMAT1 and VMAT2 are coexpressed in all chromaffin cells of the adrenal medulla. VMAT2 alone is expressed in histamine-storing enterochromaffin-like cells of the oxyntic mucosa of the stomach. The transport characteristics and pharmacology of each VMAT isoform have been directly compared after expression in digitonin-permeabilized fibroblastic (CV-1) cells, providing information about substrate feature recognition by each transporter and the role of vesicular monoamine storage in the mechanism of action of psychopharmacologic and neurotoxic agents in human. Serotonin has a similar affinity for both transporters. Catecholamines exhibit a 3-fold higher affinity, and histamine exhibits a 30-fold higher affinity, for VMAT2. Reserpine and ketanserin are slightly more potent inhibitors of VMAT2-mediated transport than of VMAT1-mediated transport, whereas tetrabenazine binds to and inhibits only VMAT2. N-methyl-4-phenylpyridinium, phenylethylamine, amphetamine, and methylenedioxymethamphetamine are all more potent inhibitors of VMAT2 than of VMAT1, whereas fenfluramine is a more potent inhibitor of VMAT1-mediated monamine transport than of VMAT2-mediated monoamine transport. The unique distributions of hVMAT1 and hVMAT2 provide new markers for multiple neuroendocrine lineages, and examination of their transport properties provides mechanistic insights into the pharmacology and physiology of amine storage in cardiovascular, endocrine, and central nervous system function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
Fuerst, T. R., Niles, E. G., Studier, F. W., & Moss, B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.21.8122 · Cited by 2,089
Chronic parkinsonism secondary to intravenous injection of meperidine analogues
Davis, G. C., Williams, A. C., Markey, S. P., Ebert, M. H., Caine, E. D., Reichert, C. M., & Kopin, I. J. (1979) · Psychiatry Research · doi:10.1016/0165-1781(79)90006-4 · Cited by 1,376
Javitch, J. A., D'Amato, R. J., Strittmatter, S. M., & Snyder, S. H. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.7.2173 · Cited by 1,263
An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2
Seed, B. (1987) · Nature · doi:10.1038/329840a0 · Cited by 681
Rindi, G., Luinetti, O., Cornaggia, M., Capella, C., & Solcia, E. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90266-f · Cited by 644
A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter
Liu, Y. (1992) · Cell · doi:10.1016/0092-8674(92)90425-c · Cited by 594
Rudnick, G., & Wall, S. C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1817 · Cited by 535
Expression cloning of a reserpine-sensitive vesicular monoamine transporter.
Erickson, J. D., Eiden, L. E., & Hoffman, B. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10993 · Cited by 487
Self-citationDopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain
Ricaurte, G. A., Guillery, R. W., Seiden, L. S., Schuster, C. R., & Moore, R. Y. (1982) · Brain Research · doi:10.1016/0006-8993(82)90198-6 · Cited by 479
Ramsay, R. R., & Singer, T. P. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)57434-8 · Cited by 412
Sulzer, D., & Rayport, S. (1990) · Neuron · doi:10.1016/0896-6273(90)90339-h · Cited by 389
Havu, N. (1986) · Digestion · doi:10.1159/000199381 · Cited by 374
Hallucinogenic Amphetamine Selectively Destroys Brain Serotonin Nerve Terminals
Ricaurte, G., Bryan, G., Strauss, L., Seiden, L., & Schuster, C. (1985) · Science · doi:10.1126/science.4023719 · Cited by 367
Differential expression of two vesicular monoamine transporters
Peter, D., Liu, Y., Sternini, C., de Giorgio, R., Brecha, N., & Edwards, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-09-06179.1995 · Cited by 333
H�kanson, R., B�ttcher, G., Ekblad, E., Panula, P., Simonsson, M., Dohlsten, M., Hallberg, T., & Sundler, F. (1986) · Histochemistry · doi:10.1007/bf00492340 · Cited by 329
Vesicular neurotransmitter transporters: from bacteria to humans.
Schuldiner, S., Shirvan, A., & Linial, M. (1995) · Physiological Reviews · doi:10.1152/physrev.1995.75.2.369 · Cited by 326
Noradrenaline: Fate and Control of Its Biosynthesis
Axelrod, J. (1971) · Science · doi:10.1126/science.173.3997.598 · Cited by 292
Ricaurte, G. A., DeLanney, L. E., Irwin, I., & Langston, J. W. (1988) · Brain Research · doi:10.1016/0006-8993(88)91309-1 · Cited by 245
Poynter, D., Pick, C. R., Harcourt, R. A., Selway, S. A., Ainge, G., Harman, I. W., Spurling, N. W., Fluck, P. A., & Cook, J. L. (1985) · Gut · doi:10.1136/gut.26.12.1284 · Cited by 243
Weihe, E., Schäfer, M. K. H., Erickson, J. D., & Eiden, L. E. (1994) · Journal of Molecular Neuroscience · doi:10.1007/bf02736730 · Cited by 229
Self-citationPeter, D., Jimenez, J., Liu, Y., Kim, J., & Edwards, R. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37272-1 · Cited by 226
Molecular Control of Cell Fate in the Neural Crest: The Sympathoadrenal Lineage
Anderson, D. J. (1993) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.16.030193.001021 · Cited by 226
Functional Identification and Molecular Cloning of a Human Brain Vesicle Monoamine Transporter
Erickson, J. D., & Eiden, L. E. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb07476.x · Cited by 159
Self-citationSchuldiner, S., Steiner‐Mordoch, S., Yelin, R., Wall, S. C., & Rudnick, G. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13357-9 · Cited by 146
Cloning and expression of the vesamicol binding protein from the marine ray Torpedo
Varoqui, H., Diebler, M., Meunier, F.-M., Rand, J. B., Usdin, T. B., Bonner, T. I., Eiden, L. E., & Erickson, J. D. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80592-x · Cited by 102
Self-citationFunctional and pharmacological significance of brain dopamine and norepinephrine storage pools
McMillen, B. A., German, D. C., & Shore, P. A. (1980) · Biochemical Pharmacology · doi:10.1016/0006-2952(80)90444-x · Cited by 102
Reinhard, J. F., Diliberto, E. J., Viveros, O. H., & Daniels, A. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.22.8160 · Cited by 102
Ketanserin binds to the monoamine transporter of chromaffin granules and of synaptic vesicles.
Darchen, F., Scherman, D., Laduron, P. M., & Henry, J. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13392-0 · Cited by 86
Darchen, F., Scherman, D., & Henry, J. P. (1989) · Biochemistry · doi:10.1021/bi00430a040 · Cited by 85
Expression and regulation of the bovine vesicular monoamine transporter gene
Krejci, É., Gasnier, B., Botton, D., Isambert, M., Sagné, C., Gagnon, J., Massoulié, J., & Henry, J. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80432-t · Cited by 76
Tetrabenazine and movement disorders
Asher, S. W., & Aminoff, M. J. (1981) · Neurology · doi:10.1212/wnl.31.8.1051 · Cited by 74
Synaptic vesicular monoamine transporter expression: distribution and pharmacologic profile
González, A. M., Walther, D. M., Pazos, Á., & Uhl, G. R. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90050-7 · Cited by 74
Pan-neuronal expression of chromogranin A in rat nervous system
Schäfer, M. K. H., Nöhr, D., Romeo, H. E., Eiden, L. E., & Weihe, E. (1994) · Peptides · doi:10.1016/0196-9781(94)90012-4 · Cited by 40
Self-citationInhibition of norepinephrine transport into synaptic vesicles by amphetamine analogs.
Knepper, S. M., Grunewald, G. L., & Rutledge, C. O. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13390-9 · Cited by 30
Expression of a bovine vesicular monoamine transporter in COS cells
Gasnier, B., Krejci, É., Botton, D., Massoulié, J., & Henry, J. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80506-7 · Cited by 18
Cited by
Histamine in the Nervous System
Haas, H. L., Sergeeva, O. A., & Selbach, O. (2008) · Physiological Reviews · doi:10.1152/physrev.00043.2007 · Cited by 1,228
Mechanisms of neurotransmitter release by amphetamines: A review
Sulzer, D., Sonders, M. S., Poulsen, N. W., & Galli, A. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.04.003 · Cited by 1,209
The diagnosis and medical management of advanced neuroendocrine tumors.
Kaltsas, G. A., Besser, G. M., & Grossman, A. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0014 · Cited by 674
Mechanisms of Amphetamine Action Revealed in Mice Lacking the Dopamine Transporter
Jones, S. R., Gainetdinov, R. R., Wightman, R. M., & Caron, M. G. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-06-01979.1998 · Cited by 631
How Addictive Drugs Disrupt Presynaptic Dopamine Neurotransmission
Sulzer, D. (2011) · Neuron · doi:10.1016/j.neuron.2011.02.010 · Cited by 581
Metadata
- Authors
- Erickson, J. D., Schafer, M. K., Bonner, T. I., Eiden, L. E., & Weihe, E.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1996-05-14
- Volume
- 93
- Issue
- 10
- Pages
- 5166-5171
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2028372004
- Cited by
- 479
- References
- 36
- FWCI
- 5.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.